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Abstract 
Background: Emphasis  on the misuse of antibacterials in Albania 
and an increased sensibility on the antibacterial resistance have been reported 
in the grey literature lately. However, until now there are no consistent data 
on antibacterial use, its related misuse and antibacterial resistance, either 
other reports produced by health institutions. 
Objective: The objective of this study is to assess the trend of antibacterial 
utilization reimbursed by the  Health Insurance Institute (HII) in the 
ambulatory care in Albania during the period 2011-2012. 
Materials and Methods:  Data  from the HII database for all the reimbursed 
and dispensed antibacterial in the ambulatory care were taken and the 
methodology of ATC/DDD for the study of antibacterial utilization was 
applied. Antibacterial grouped in ATC class were measured in defines daily 
doses (DDDs) and DDD/1000 inhabitant/day (DIDs) and then compared 
with the data of the European Surveillance of Antimicrobial Consumption 
Network (ESAC-Net) reports. 
Results:Results of the total consumption of antibacterials reimbursed by the 
HII measured during 2011 are (3.174 DIDs) and in 2012 (2.794 DIDs).The 
penicillin’s  total consumption in  2011  are  (1.604 DID) and in 2012 (1.306 
DID). From 2011 to 2012 there are no significant differences in the total 
antibacterial consumption. However, an enhancement of the use of  third 
generation of cephalosporin’s was distinguished within the class of 
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cephalosporin’s during the year 2012 (0.038 DID) whereas in the year 2011 
was (0.006 DID).  
Conclusions:The quantities of antibacterial reimbursed for HII covered 
population during 2011 and 2012 are lower than the average consumption of 
EU/EAA countries part of ESAC-Net project. However, cephalosporin’s and 
tetracycline’s quantities reimbursed and dispensed were similar with the 
relative data of some countries of EU/EAA countries part of the ESAC-Net 
project. 
 
Keywords: Antibacterial consumption, drug utilization, ambulatory care, 
Albania 
 
Introduction 
The use of antibacterial has been very important worldwide and has 
brought huge benefits in terms of health and fundamental in preventing and 
decreasing infection diseases.(WHO, 2000, 2001) 
The positive correlation between the use of  antibacterial  and  
antibacterial resistance in Europe has been reported (Goossens, 2005) and 
preliminary investigations revealed the presence of clusters of consumption 
associated  with  antibacterial resistance. Another study reported a positive 
association between highly significant antibacterial resistance and the use of 
antibiotics. (Masiero, 2007) 
Since 2001 the WHO is engaged  in guiding the response of  
antibacterial resistance with the rational use of old antibacterial, in 
implementing strategies and country policies for the proper surveillance. The 
WHO has issued a global strategy and guidelines to help countries in setting 
up systems to monitor  antibacterial  resistance and implement interventions 
(WHO, 2001.2). The collection and analysis of the antibacterial consumption 
from EU/EAA countries, both in the community and in the hospital sector is 
done by the European Surveillance of Antimicrobial Consumption Network, 
(ESAC-Net), founded and coordinated by the European Centre for Disease 
Prevention and Control (ECDC) (ECDC, 2013). 
Emphasis on the misuse of antibacterials in Albania and an increased 
sensibility on the antibacterial resistance  have  been reported in the grey 
literature lately. However, until now there are no data on antibacterials, use, 
its related misuse and antibacterial resistance. Reports produced by health 
institutions in Albania have not tackled these problems.  
For these reasons, the aim of this study is to define quantitatively the 
antibacterial consumption in Albania, but due to the fact that actually, there 
are not reliable databases for the antibacterial consumption, and generally for 
the drug consumption, we were able to analyse only the antibacterial 
consumption in the ambulatory care prescribed by the physicians contracted 
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by the  HII  and dispensed by the community pharmacies to the   covered  
population with an active healthcare card. 
 In fact, the only institution that keeps track of the drug consumption 
is the HII, that gathers data only for the patients in the ambulatory care, 
which  benefit reimbursed services for financial purpose. 
According to the regulatory environment, all the population should be 
insured and covered by HII, which should reimburse them for the health 
expenditure, like drug prescription and consumption. This permits the 
traceability of the drug consumption, in this case of the antibacterial (LAW, 
1994). 
We refer to the covered population to the population with an active 
healthcare card, the one that benefits from the HII  scheme. 
In this study we gathered the data from the HII and determined the 
antibacterial consumption of every class. ATC/DDD index offered by the 
WHO (version 2013) was used, DDD and DID per every antibacterial used 
in Albania was found. Final data were compared with those of  ESAC-Net  
project, which collects reference data on the consumption of antimicrobials 
for systematic use in the community and in the hospital sector in EU and 
EEA/EFTA countries through the European Surveillance System (WHO, 
2013). 
This data will allow the  analysis  of the reimbursed antibacterial 
from the  HII in the ambulatory care to the  covered  population, and 
compare them with the available data of the  EU/EAA countries part of the 
ESAC-Net project. 
 
Methods 
Data for antibacterial reimbursed in the ambulatory care were 
obtained by HII for the years 2011 and 2012. This data include all the 
antibacterials prescribed by the physicians contracted by the HII to the 
covered  population and dispensed to them by the community pharmacies.  
The antibacterial were divided by ATC code and the  quantities  were  
expressed as in units of the pharmaceutical form (tablets, pills bottles, 
ampoules etc.).Total amount of active principle was found for every  
antibacterial classified by ATC code and pharmaceutical form for the years 
2011 and 2012.  
Total amount of DDDs was found for every antibacterial classified by 
ATC code and pharmaceutical form for the years 2011 and 2012. Referring 
to the guidelines of WHO for using the ATC/DDD system which gives ATC 
classification and DDD assignment linked to the ATC level. ATC/DDD 
values were taken by the WHO web updated ATC/DDD index in 7 January 
2013 (WHO, 2013). 
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DDDs per 1000 inhabitants per day were found using the guidelines 
of WHO:  
DDDs per 1000 inhabitants per day = (Total consumption measured 
in DDDs * 1000 inhabitants) / (No. Population * 365 days).  (Hutchinson, 
2004). 
 The population in this case is represented by the number of covered  
population  by HII with  an  active  healthcare  card. 
Data of the European countries were taken by the web ESAC- Net 
active database (country data 2011, which is the latest year reported) (ECDC, 
2011) and then compared with the HII data for the antibacterial consumption 
of covered population in Albania. 
Tables, graphics and calculations were made in an excel sheet. 
 
Results 
  Results  of the total consumption of antibacterials reimburesed by the 
HII measured during 2011 are 3.174 DIDs and in 2012  are  2.794 DIDs. 
  The values  of  DDDs  per  1000  inhabitants  per  day  for  every  
antibacterial  class in  the  Albanian  covered  population,  HII  in  2011  and  
2012 are presented in tab. 1 and graph 1. 
  The penicillin was slightly reduced but still they are the most notable 
class of the antibacterials being reimbursed with 50.5% of the total 
consumption in 2011 of (1.604 DID) and 46.7% of the total consumption in 
2012 of (1.306 DID), shifting to cephalosporin’s, tetracycline’s, macrolides 
and other substances of antibacterial.  
From 2011 to 2012 there are no significant differences in the total 
antibacterial consumption. However, an enhancement of the use of third 
generation of cephalosporin’s was distinguished within the class of 
cephalosporin’s during the year 2012 (0.038 DID) whereas in the year 2011 
was (0.006 DID).  
The scheme of reimbursement for antibacterial during 2011-2012 has 
not meet significant changes regarding the reimbursed items, only one 
penicillin sub-class, J01CE01was taken off the reimbursement scheme in the 
2012 list of reimbursement by the HII. 
 
Discussion  
  The antibacterial consumption of the HII covered  population during 
2011 and 2012 is lower than  the  consumption  of  antibacterials  in the  
countries  part  of  ESAC-Network  during  2011 (ESAC Report, 14), which 
varies form 11.4 DIDs of the Netherlands to the 35.1 DIDs of Greece, with a 
median of 19.5 DIDs for all the EU countries.  
  The consumption remains far lower for each class of antibiotics with 
little exceptions as follows (ESAC Report, 14). The  consumption  of  
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tetracycline’s in Albania was similar to Romania (0.1 DIDs), the 
consumption of cephalosporin’s was  similar  to United Kingdom (0.4DIDs), 
Latvia (0.5DIDs) and  overcomes  the  consumption  in  Netherlands 
(<0.1DIDs),  Sweden (0.2DIDs),  Norway (0.1 DIDs),  Slovenia 
(0.3DIDs)and  Denmark (0.1DIDs). Finally the consumption of macrolides is 
similar to Sweden (0.6 DIDs). 
In addition, from 2011 to 2012 there has been a slight decrease in 
antibacterial reimbursement and consumption, this could be linked with the 
increased enforcement of the protocols of treatment for the covered 
population.  
The above mentioned low consumption of reimbursed antibacterial 
may depend from several factors like the low use of insurance services or 
low access to these services from  the covered population in the ambulatory 
care. Due to the fact that we don’t have data for the  antibacterial 
consumption which are paid out of pocket, in the ambulatory care in Albania, 
we are not able to determine the overall consumption of  antibacterial in the 
country.  
We were not able to determine whether the population chose to not 
benefit  from  the reimbursement of the antibacterial prescriptions, bypassing 
the medical protocols and  the  HII procedures, which can be a clue to the 
inappropriate prescription.   
A recent reports by (Malaj, 2012)  represent the differences between 
reimbursed and non reimbursed antibacterial prescription and suggested that 
there is a tendency of the physicians to prescribe last generation antibacterial, 
which are more expensive, when prescriptions are not reimbursed and that 
these prescriptions weren’t filled correctly, with missing information. 
Still our study is limited to the covered  population, which have an 
active healthcare  card and can benefit  from the  reimbursed services. The 
other population is not included because they don’t have the healthcare card 
and don’t have access to the reimbursed services, in this case to the 
reimbursed  antibacterial. 
For these reasons, actions must be taken to monitor and control the 
prescribing and dispensing of antibacterial, in order to quantify the overall 
antibacterial consumption, even if they are paid out of pocket. 
Even if this analysis does not show the total consumption of 
antibacterial class of drugs in Albania, it may be a first step to sensitize the 
healthcare institutions to give a re-dimension of the protocols of the HII and 
monitor the non-official consumption of antibacterial and antibacterial 
resistance too.     
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Tab. 1Average  values  of  DDDs  per  1000  inhabitants  per  day  for  every  antibacterial  
class in  the  Albanian  covered  population,  HII  in  2011  and  2012 
Antibacterial ATC DDDs per 1000 inhabitants per 
day 
2011 2012 
Penicilins J01C 1.60 1.41 
Penicillin’s with extended spectrum J01CA 0.57 0.52 
Combinations of penicillin’s, incl. β-
lactamase inhib. 
J01CR 1.02 0.88 
Beta-lactamase sensitive penicillins J01CE 0.0087 0.0004 
Cephalosporins J01D 0.37 0.41 
First-generation cephalosporin’s J01DB 0.20 0.19 
Second-generation cephalosporin’s J01DC 0.17 0.17 
Third-generation cephalosporin’s J01DD 0.003 0.013 
Macrolides J01F 0.57 0.58 
Quinolones J01M 0.23 0.23 
Tetracyclines J01A 0.13 0.15 
Sulphonamides J01E 0.056 0.055 
Others 0.44 0.42 
Total 3.4050 3.2469 
 
Graph 1.Values of DDDs per 1000 inhabitants per day for every  antibacterialclass in the 
Albanian  covered population HII in 2011 and 2012 
 
 
 
 
 
 
 
